Homologous role of CovRS two-component regulatory system in NAD+-glycohydrolase activity in Streptococcus dysgalactiae subsp. equisimilis as in Streptococcus pyogenes
Corresponding Author
Tadao Hasegawa
Department of Bacteriology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
Tadao Hasegawa, Department of Bacteriology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan. e-mail: [email protected]Search for more papers by this authorMasakado Matsumoto
Department of Microbiology and Medical Zoology, Aichi Prefectural Institute of Public Health, Nagoya, Japan
Search for more papers by this authorNanako Hata
Department of Microbiology, Nagoya City University Hospital, Nagoya, Japan
Search for more papers by this authorHisako Yano
Department of Infection Control and Prevention Nursing, Nagoya City University Graduate School of Nursing, Nagoya, Japan
Search for more papers by this authorMasanori Isaka
Department of Bacteriology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
Search for more papers by this authorIchiro Tatsuno
Department of Bacteriology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
Search for more papers by this authorCorresponding Author
Tadao Hasegawa
Department of Bacteriology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
Tadao Hasegawa, Department of Bacteriology, Nagoya City University Graduate School of Medical Sciences, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan. e-mail: [email protected]Search for more papers by this authorMasakado Matsumoto
Department of Microbiology and Medical Zoology, Aichi Prefectural Institute of Public Health, Nagoya, Japan
Search for more papers by this authorNanako Hata
Department of Microbiology, Nagoya City University Hospital, Nagoya, Japan
Search for more papers by this authorHisako Yano
Department of Infection Control and Prevention Nursing, Nagoya City University Graduate School of Nursing, Nagoya, Japan
Search for more papers by this authorMasanori Isaka
Department of Bacteriology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
Search for more papers by this authorIchiro Tatsuno
Department of Bacteriology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan
Search for more papers by this authorAbstract
Streptococcal toxic shock syndrome (STSS) is primarily caused by Streptococcus pyogenes, but it may also be caused by Streptococcus dysgalactiae subsp. equisimilis (SDSE). The analyses of S. pyogenes have revealed the important roles of NAD+-glycohydrolase (Nga) and CovR/CovS, a two-component regulatory system. We examined these factors in SDSE by analyzing mainly two isogenic SDSE strains (12-10-1 and 12-10-3) from the blood of a patient with STSS. The Nga activities were measured and the nucleotide sequences of covR and covS genes were determined. We detected one nucleotide difference between the covR gene of 12-10-1 and that of 12-10-3, and the Nga activity of 12-10-1 was approximately 6.8-fold more than that of 12-10-3. The introduction of covR of 12-10-3 into 12-10-1 significantly reduced the Nga activity, but the introduction of 12-10-1 covR into itself had only a little effect. In addition, the knockout of covR or covS of 12-10-3 remarkably increased the Nga activity. We are the first to report that strains with wild-type and mutated covR were isolated simultaneously from an SDSE STSS patient and that the CovR/CovS two-component regulatory system is involved in the Nga activity in SDSE as well as in S. pyogenes.
References
- 1Wagner JG, Schlievert PM, Assimacopoulos AP, Stoehr JA, Carson PJ, Komadina K. Acute group G streptococcal myositis associated with streptococcal toxic shock syndrome: case report and review. Clin Infect Dis 1996; 23: 1159–61.
- 2Natoli S, Fimiani C, Faglieri N, Laurenzi L, Calamaro A, Frasca AM, et al. Toxic shock syndrome due to group C streptococci. A case report. Intensive Care Med 1996; 22: 985–9.
- 3Hirose Y, Yagi K, Honda H, Shibuya H, Okazaki E. Toxic shock-like syndrome caused by non-group A beta-hemolytic streptococci. Arch Intern Med 1997; 157: 1891–4.
- 4Roth S, Andrassy K, Schmidt KH, Gunther E, Ritz E. Febrile lady with acute renal failure and desquamating erythema. Am J Kidney Dis 1999; 34: 150–4.
- 5Vandamme P, Pot B, Falsen E, Kersters K, Devriese LA. Taxonomic study of Lancefield streptococcal groups C, G, and L (Streptococcus dysgalactiae) and proposal of S. dysgalactiae subsp. equisimilis subsp. nov. Int J Syst Bacteriol 1996; 46: 774–81.
- 6Humar D, Datta V, Bast DJ, Beall B, De Azavedo JC, Nizet V. Streptolysin S and necrotising infections produced by group G streptococcus. Lancet 2002; 359: 124–9.
- 7Barnham MR, Weightman NC, Anderson AW, Tanna A. Streptococcal toxic shock syndrome: a description of 14 cases from North Yorkshire, UK. Clin Microbiol Infect 2002; 8: 174–81.
- 8Loubinoux J, Plainvert C, Collobert G, Touak G, Bouvet A, Poyart C. Adult invasive and noninvasive infections due to Streptococcus dysgalactiae subsp. equisimilis in France from 2006 to 2010. J Clin Microbiol 2013; 51: 2724–7.
- 9Cunningham MW. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000; 13: 470–511.
- 10Davies MR, McMillan DJ, Beiko RG, Barroso V, Geffers R, Sriprakash KS, et al. Virulence profiling of Streptococcus dysgalactiae subspecies equisimilis isolated from infected humans reveals 2 distinct genetic lineages that do not segregate with their phenotypes or propensity to cause diseases. Clin Infect Dis 2007; 44: 1442–54.
- 11McNeilly CL, McMillan DJ. Horizontal gene transfer and recombination in Streptococcus dysgalactiae subsp. equisimilis. Front Microbiol 2014; 5: 676.
- 12Hashikawa S, Iinuma Y, Furushita M, Ohkura T, Nada T, Torii K, et al. Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome. J Clin Microbiol 2004; 42: 186–92.
- 13Shimomura Y, Okumura K, Murayama SY, Yagi J, Ubukata K, Kirikae T, et al. Complete genome sequencing and analysis of a Lancefield group G Streptococcus dysgalactiae subsp. equisimilis strain causing streptococcal toxic shock syndrome (STSS). BMC Genom 2011; 12: 17.
- 14Tatsuno I, Sawai J, Okamoto A, Matsumoto M, Minami M, Isaka M, et al. Characterization of the NAD-glycohydrolase in streptococcal strains. Microbiology 2007; 153: 4253–60.
- 15Sumby P, Porcella SF, Madrigal AG, Barbian KD, Virtaneva K, Ricklefs SM, et al. Evolutionary origin and emergence of a highly successful clone of serotype M1 group A Streptococcus involved multiple horizontal gene transfer events. J Infect Dis 2005; 192: 771–82.
- 16Turner CE, Abbott J, Lamagni T, Holden MT, David S, Jones MD, et al. Emergence of a new highly successful acapsular group A Streptococcus clade of genotype emm89 in the United Kingdom. MBio 2015; 6: e00622–15.
- 17Zhu L, Olsen RJ, Nasser W, de la Riva Morales I, Musser JM. Trading capsule for increased cytotoxin production: contribution to virulence of a newly emerged clade of emm89 Streptococcus pyogenes. MBio 2015; 6: e01378-15.
- 18Friães A, Machado MP, Pato C, Carrico J, Melo-Cristino J, Ramirez M. Emergence of the same successful clade among distinct populations of emm89 Streptococcus pyogenes in multiple geographic regions. MBio 2015; 6: e01780-15.
- 19Levin JC, Wessels MR. Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus. Mol Microbiol 1998; 30: 209–19.
- 20Federle MJ, McIver KS, Scott JR. A response regulator that represses transcription of several virulence operons in the group A streptococcus. J Bacteriol 1999; 181: 3649–57.
- 21Ferretti JJ, McShan WM, Ajdic D, Savic DJ, Savic G, Lyon K, et al. Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci USA 2001; 98: 4658–63.
- 22Graham MR, Smoot LM, Migliaccio CA, Virtaneva K, Sturdevant DE, Porcella SF, et al. Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling. Proc Natl Acad Sci USA 2002; 99: 13855–60.
- 23Engleberg NC, Heath A, Miller A, Rivera C, DiRita VJ. Spontaneous mutations in the CsrRS two-component regulatory system of Streptococcus pyogenes result in enhanced virulence in a murine model of skin and soft tissue infection. J Infect Dis 2001; 183: 1043–54.
- 24Sumby P, Whitney AR, Graviss EA, DeLeo FR, Musser JM. Genome-wide analysis of group A streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog 2006; 2: e5.
- 25Ato M, Ikebe T, Kawabata H, Takemori T, Watanabe H. Incompetence of neutrophils to invasive group A streptococcus is attributed to induction of plural virulence factors by dysfunction of a regulator. PLoS ONE 2008; 3: e3455.
- 26Ikebe T, Ato M, Matsumura T, Hasegawa H, Sata T, Kobayashi K, et al. Highly frequent mutations in negative regulators of multiple virulence genes in group A streptococcal toxic shock syndrome isolates. PLoS Pathog 2010; 6: e1000832.
- 27Walker MJ, Hollands A, Sanderson-Smith ML, Cole JN, Kirk JK, Henningham A, et al. DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med 2007; 13: 981–5.
- 28Cole JN, Pence MA, von Kockritz-Blickwede M, Hollands A, Gallo RL, Walker MJ, et al. M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A Streptococcus. MBio 2010; 1: e00191-10.
- 29Masuno K, Okada R, Zhang Y, Isaka M, Tatsuno I, Shibata S, et al. Simultaneous isolation of emm89-type Streptococcus pyogenes strains with a wild-type or mutated covS gene from a single streptococcal toxic shock syndrome patient. J Med Microbiol 2014; 63: 504–7.
- 30Watanabe S, Shimomura Y, Ubukata K, Kirikae T, Miyoshi-Akiyama T. Concomitant regulation of host tissue-destroying virulence factors and carbohydrate metabolism during invasive diseases induced by group G streptococci. J Infect Dis 2013; 208: 1482–93.
- 31Okada N, Tatsuno I, Hanski E, Caparon M, Sasakawa C. Streptococcus pyogenes protein F promotes invasion of HeLa cells. Microbiology 1998; 144: 3079–86.
- 32Hasegawa T, Minami M, Okamoto A, Tatsuno I, Isaka M, Ohta M. Characterization of a virulence-associated and cell-wall-located DNase of Streptococcus pyogenes. Microbiology 2010; 156: 184–90.
- 33Lukomski S, Hoe NP, Abdi I, Rurangirwa J, Kordari P, Liu M, et al. Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization. Infect Immun 2000; 68: 535–42.
- 34Stevens DL, Salmi DB, McIndoo ER, Bryant AE. Molecular epidemiology of nga and NAD glycohydrolase/ADP-ribosyltransferase activity among Streptococcus pyogenes causing streptococcal toxic shock syndrome. J Infect Dis 2000; 182: 1117–28.
- 35Hasegawa T, Okamoto A, Kamimura T, Tatsuno I, Hashikawa SN, Yabutani M, et al. Detection of invasive protein profile of Streptococcus pyogenes M1 isolates from pharyngitis patients. APMIS 2010; 118: 167–78.
- 36Tatsuno I, Okada R, Zhang Y, Isaka M, Hasegawa T. Partial loss of CovS function in Streptococcus pyogenes causes severe invasive disease. BMC Res Notes 2013; 6: 126.
- 37Tatsuno I, Isaka M, Minami M, Hasegawa T. NADase as a target molecule of in vivo suppression of the toxicity in the invasive M-1 group A Streptococcal isolates. BMC Microbiol 2010; 10: 144.